| Deployment of convalescent plasma for the prevention and treatment of COVID-19 EM Bloch, S Shoham, A Casadevall, BS Sachais, B Shaz, JL Winters, ... The Journal of clinical investigation 130 (6), 2757-2765, 2020 | 1026 | 2020 |
| The Xs and Y of immune responses to viral vaccines SL Klein, A Jedlicka, A Pekosz The Lancet infectious diseases 10 (5), 338-349, 2010 | 980 | 2010 |
| IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses DJ Lenschow, C Lai, N Frias-Staheli, NV Giannakopoulos, A Lutz, T Wolff, ... Proceedings of the National Academy of Sciences 104 (4), 1371-1376, 2007 | 687 | 2007 |
| Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells A Ibricevic, A Pekosz, MJ Walter, C Newby, JT Battaile, EG Brown, ... Journal of virology 80 (15), 7469-7480, 2006 | 541 | 2006 |
| Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model TE Sussan, S Gajghate, RK Thimmulappa, J Ma, JH Kim, K Sudini, ... PloS one 10 (2), e0116861, 2015 | 527 | 2015 |
| Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins J Zhang, A Pekosz, RA Lamb Journal of virology 74 (10), 4634-4644, 2000 | 524 | 2000 |
| Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population SL Klein, A Pekosz, HS Park, RL Ursin, JR Shapiro, SE Benner, ... The Journal of clinical investigation 130 (11), 6141-6150, 2020 | 521 | 2020 |
| Efficacy of antibodies and antiviral drugs against Covid-19 Omicron variant E Takashita, N Kinoshita, S Yamayoshi, Y Sakai-Tagawa, S Fujisaki, M Ito, ... New England Journal of Medicine 386 (10), 995-998, 2022 | 457 | 2022 |
| Efficacy of antibodies and antiviral drugs against Omicron BA. 2.12. 1, BA. 4, and BA. 5 subvariants E Takashita, S Yamayoshi, V Simon, H Van Bakel, EM Sordillo, A Pekosz, ... New England Journal of Medicine 387 (5), 468-470, 2022 | 356 | 2022 |
| Influenza A Virus M2 Ion Channel Activity Is Essential for Efficient Replication in Tissue Culture M Takeda, A Pekosz, K Shuck, LH Pinto, RA Lamb Journal of virology 76 (3), 1391-1399, 2002 | 347 | 2002 |
| Early outpatient treatment for Covid-19 with convalescent plasma DJ Sullivan, KA Gebo, S Shoham, EM Bloch, B Lau, AG Shenoy, ... New England Journal of Medicine 386 (18), 1700-1711, 2022 | 296 | 2022 |
| Distinct domains of the influenza a virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production MF McCown, A Pekosz Journal of virology 80 (16), 8178-8189, 2006 | 282 | 2006 |
| COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva N Pisanic, PR Randad, K Kruczynski, YC Manabe, DL Thomas, A Pekosz, ... Journal of clinical microbiology 59 (1), 10.1128/jcm. 02204-20, 2020 | 281 | 2020 |
| SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals H Kared, AD Redd, EM Bloch, TS Bonny, H Sumatoh, F Kairi, D Carbajo, ... The Journal of clinical investigation 131 (5), 2021 | 278 | 2021 |
| Antigen-based testing but not real-time polymerase chain reaction correlates with severe acute respiratory syndrome coronavirus 2 viral culture A Pekosz, V Parvu, M Li, JC Andrews, YC Manabe, S Kodsi, DS Gary, ... Clinical Infectious Diseases 73 (9), e2861-e2866, 2021 | 267 | 2021 |
| The Influenza A Virus M2 Cytoplasmic Tail Is Required for Infectious Virus Production and Efficient Genome Packaging MF McCown, A Pekosz Journal of virology 79 (6), 3595-3605, 2005 | 266 | 2005 |
| Interferon-producing cells fail to induce proliferation of naive T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells A Krug, R Veeraswamy, A Pekosz, O Kanagawa, ER Unanue, M Colonna, ... The Journal of experimental medicine 197 (7), 899-906, 2003 | 241 | 2003 |
| Structure and intracellular targeting of the SARS-coronavirus Orf7a accessory protein CA Nelson, A Pekosz, CA Lee, MS Diamond, DH Fremont Structure 13 (1), 75-85, 2005 | 234 | 2005 |
| The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles SR Schaecher, JM Mackenzie, A Pekosz Journal of virology 81 (2), 718-731, 2007 | 232 | 2007 |
| Exuberant fibroblast activity compromises lung function via ADAMTS4 DF Boyd, EK Allen, AG Randolph, XJ Guo, Y Weng, CJ Sanders, ... Nature 587 (7834), 466-471, 2020 | 215 | 2020 |
Sabra KleinMolecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public HealthVerified email at jhsph.edu
